Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Akers Biosciences
(NQ:
AKER
)
3.210
USD
-0.110 (-3.31%)
Official Closing Price
Updated: 5:27 PM EDT, Apr 9, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Akers Biosciences
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline – August 13, 2018
July 06, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER) and...
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline – AKER
July 04, 2018
Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER) and certain of its officers. The class action, filed in...
From
GlobeNewswire News Releases
AKER LOSS NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Akers Biosciences, Inc. – AKER
July 03, 2018
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15,...
From
Business Wire News Releases
34 Stocks Moving In Tuesday's Mid-Day Session
July 03, 2018
Gainers Tengasco, Inc. (NYSE: TGC) shares jumped 62.3 percent to $1.42. Anavex Life Sciences Corp (NASDAQ: AVXL) jumped 44 ...
Tags
UONE
EPZM
PAM
From
Benzinga
Benzinga Pro's 5 Stocks To Watch Today
July 03, 2018
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a ...
Tags
VEON
News
AVXL
From
Benzinga
Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
July 03, 2018
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces agreements with six more Independent Sales...
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - AKER
June 30, 2018
From
ACCESSWIRE
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Akers Biosciences, Inc. to Contact the Firm
June 29, 2018
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. (“Akers Biosciences” or the “Company”) (NASDAQ:AKER).
From
Business Wire News Releases
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline - August 13, 2018
June 29, 2018
From
ACCESSWIRE
Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange
June 29, 2018
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that the Company has requested that trading in the...
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - AKER
June 28, 2018
From
ACCESSWIRE
AKER NOTICE: Pawar Law Announces a Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
June 28, 2018
From
ACCESSWIRE
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Akers Biosciences, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Clas
June 27, 2018
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New...
From
Business Wire News Releases
INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
June 25, 2018
INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc.
From
Business Wire News Releases
NASDAQ:AKER Shareholder Notice: Lawsuit Alleges Misleading Statements by Akers Biosciences, Inc
June 25, 2018
San Diego, CA -- (SBWIRE) -- 06/25/2018 -- An investor, who purchased shares of Akers Biosciences, Inc. (NASDAQ: AKER), filed a lawsuit over alleged violations of Federal Securities Laws by Akers...
From
SBWire - Latest Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - AKER
June 23, 2018
From
ACCESSWIRE
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline – August 13, 2018
June 22, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER) and...
From
GlobeNewswire News Releases
Pomerantz Law Firm Announces the Filing of a Class Action against Akers Biosciences, Inc. and Certain Officers – AKER
June 20, 2018
Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER) and certain of its officers. The class action, filed in...
From
GlobeNewswire News Releases
Safirstein Metcalf LLP Announces that a Class Action Has Been Filed Against Akers Biosciences, Inc. – AKER
June 20, 2018
Safirstein Metcalf LLP announces that a class action has been filed on behalf of those who purchased securities of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ:AKER) between May 15, 2017...
From
GlobeNewswire News Releases
AKERS BIOSCIENCES, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Lawsuit has Been Filed in the United States District Court for the District o
June 20, 2018
From
ACCESSWIRE
Akers Alert: Bernstein Liebhard LLP Announces Investigation of Akers Biosciences, Inc. - AKER
June 20, 2018
Bernstein Liebhard LLP is investigating potential securities fraud claims on behalf of shareholders of Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER). If you purchased Akers...
From
GlobeNewswire News Releases
AKERS BIOSCIENCES, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District o
June 19, 2018
Lead Plaintiff Deadline is August 13, 2018
From
GlobeNewswire News Releases
AKER LOSS NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Akers Biosciences, Inc. – AKER
June 19, 2018
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15,...
From
Business Wire News Releases
Akers Class Action: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Akers Biosciences, Inc. - AKER
June 19, 2018
Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Akers Biosciences, Inc. (“Akers” or the “Company”)...
From
GlobeNewswire News Releases
Robbins Arroyo LLP: Akers Biosciences, Inc. (AKER) Misled Shareholders According to a Recently Filed Class Action
June 18, 2018
Do you own shares of Akers Biosciences, Inc.? Robbins Arroyo LLP is investigating claims on behalf of shareholders of Akers.
From
Business Wire News Releases
AKER REMINDER: Pawar Law Reminds of Important August 13, 2018 Lead Plaintiff Deadline in Class Action - AKER
June 18, 2018
From
ACCESSWIRE
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akers Biosciences, Inc. (Nasdaq: AKER) To Conta
June 18, 2018
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New...
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akers Biosciences, Inc. - AKER
June 16, 2018
From
ACCESSWIRE
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
June 15, 2018
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc.
From
Business Wire News Releases
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akers Biosciences, Inc. To Contact The Firm
June 15, 2018
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER).
From
PR Newswire
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.